Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NU SKIN ENTERPRISES, INC.NUS · Entity 6223 | Chief Scientific Officer | March 01, 2023 | March 03, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NU SKIN ENTERPRISES, INC.
Report date March 01, 2023 · Filed March 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 21,234 |
Ending reported balance
After 2023-03-02 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2023-03-01 · Exercise / conversion · Acquired 68,485 · Balance 89,719 Row 2 · 2023-03-01 · Sale · Disposed 68,485 · Balance 21,234 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.89 to $40.80, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Row 3 · 2023-03-02 · Exercise / conversion · Acquired 600 · Balance 21,834 Row 4 · 2023-03-02 · Exercise / conversion · Acquired 24,400 · Balance 46,234 Row 5 · 2023-03-02 · Sale · Disposed 25,000 · Balance 21,234 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.31 to $41.21, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.63 · Expires 2023-03-02 | Direct | 0 |
Reported balance
After 2023-03-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2023-03-01 · Exercise / conversion · Disposed 42,485 · Balance 0 F4: Currently exercisable in full. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.63 · Expires 2023-03-02 | Direct | 600 |
Reported balance
After 2023-03-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2023-03-01 · Exercise / conversion · Disposed 26,000 · Balance 600 F4: Currently exercisable in full. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.63 · Expires 2023-03-02 | Direct | 0 |
Reported balance
After 2023-03-02 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2023-03-02 · Exercise / conversion · Disposed 600 · Balance 0 F4: Currently exercisable in full. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.45 · Expires 2027-02-15 | Direct | 59,410 |
Reported balance
After 2023-03-02 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2023-03-02 · Exercise / conversion · Disposed 24,400 · Balance 59,410 F4: Currently exercisable in full. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld in irrevocable family trust | 78,068 |
Reported balance
Holding disclosure · report date 2023-03-01 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 78,068 F3: This report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.89 to $40.80, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.31 to $41.21, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
F3: This report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F4: Currently exercisable in full.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2020 Filed Mar 6, 2020 21:41 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 321 | $25.57 | $8,207.97 |
DisclosureSEC source: 0001021561-20-000023 · edgar.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,525 F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units. Read SEC document |
| February 15, 2020 Filed Feb 19, 2020 21:43 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 562 | $30.45 | $17,112.90 |
DisclosureSEC source: 0001021561-20-000005 · edgar.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,846 Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:43 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 331 | $59.74 | $19,773.94 |
DisclosureSEC source: 0001021561-19-000024 · edgar.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,408 F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 23:56 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantEmployee Stock Option (Right to Buy) · Derivative | 9,264 | $0.00 Strike: $71.99 | $0.00 |
DisclosureSEC source: 0001021561-19-000008 · edgar.xml · derivative · entry 3 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,264 Underlying: Class A Common Stock · 9,264 shares Expires 2025-03-08 F3 · shares: On March 8, 2018, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 22, 2019, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 23:56 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantEmployee Stock Option (Right to Buy) · Derivative | 10,223 | $0.00 Strike: $50.68 | $0.00 |
DisclosureSEC source: 0001021561-19-000008 · edgar.xml · derivative · entry 2 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,562 Underlying: Class A Common Stock · 10,223 shares Expires 2024-03-04 F2 · shares: On March 4, 2017, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 22, 2019, the performance criteria were met, resulting in the vesting of the amount shown above. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 23:56 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantEmployee Stock Option (Right to Buy) · Derivative | 9,551 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001021561-19-000008 · edgar.xml · derivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,485 Underlying: Class A Common Stock · 9,551 shares Expires 2023-03-02 F1 · shares: On March 2, 2016, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 22, 2019, the performance criteria were met, resulting in the vesting of the amount shown above. Read SEC document |
| February 15, 2019 Filed Feb 21, 2019 00:05 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 141 | $63.09 | $8,895.69 |
DisclosureSEC source: 0001184201-19-000015 · edgar.xml · nonDerivative · entry 2 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,739 Read SEC document |
| February 15, 2019 Filed Feb 21, 2019 00:05 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantClass A Common Stock | 4,502 | $0.00 | $0.00 |
DisclosureSEC source: 0001184201-19-000015 · edgar.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,880 Read SEC document |
| February 09, 2019 Filed Feb 13, 2019 00:23 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $54.08 | $0.00 |
DisclosureSEC source: 0001184201-19-000008 · edgar.xml · derivative · entry 4 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 7,500 shares Expires 2019-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: In accordance with the terms of the Issuer's stock incentive plans, these options were automatically net exercised immediately prior to their expiration. F5 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| February 09, 2019 Filed Feb 13, 2019 00:23 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 6,538 | $67.06 | $438,438.28 |
DisclosureSEC source: 0001184201-19-000008 · edgar.xml · nonDerivative · entry 2 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,378 F2 · shares: In accordance with the terms of the Issuer's stock incentive plans, these shares were withheld by the Issuer to cover the option exercise price and tax withholding obligations related to the automatic net exercise of options immediately prior to their expiration. Read SEC document |
| February 09, 2019 Filed Feb 13, 2019 00:23 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 7,500 | $54.08 | $405,600.00 |
DisclosureSEC source: 0001184201-19-000008 · edgar.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,916 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: In accordance with the terms of the Issuer's stock incentive plans, these shares were acquired from the automatic net exercise of options immediately prior to their expiration. Read SEC document |
| August 09, 2018 Filed Aug 9, 2018 21:27 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 350 | $0.00 Strike: $41.27 | $0.00 |
DisclosureSEC source: 0001021561-18-000123 · edgar.xml · derivative · entry 11 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,900 Underlying: Class A Common Stock · 350 shares Expires 2020-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| August 09, 2018 Filed Aug 9, 2018 21:27 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 250 | $0.00 Strike: $41.49 | $0.00 |
DisclosureSEC source: 0001021561-18-000123 · edgar.xml · derivative · entry 10 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 250 shares Expires 2019-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| August 09, 2018 Filed Aug 9, 2018 21:27 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 600 | $84.02 | $50,412.00 |
DisclosureSEC source: 0001021561-18-000123 · edgar.xml · nonDerivative · entry 6 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,416 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.01 to $84.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| August 09, 2018 Filed Aug 9, 2018 21:27 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 250 | $41.49 | $10,372.50 |
DisclosureSEC source: 0001021561-18-000123 · edgar.xml · nonDerivative · entry 5 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2018 Filed Aug 9, 2018 21:27 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 350 | $41.27 | $14,444.50 |
DisclosureSEC source: 0001021561-18-000123 · edgar.xml · nonDerivative · entry 4 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,766 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2018 Filed Aug 9, 2018 21:27 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $41.49 | $0.00 |
DisclosureSEC source: 0001021561-18-000123 · edgar.xml · derivative · entry 9 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Class A Common Stock · 6,000 shares Expires 2019-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| August 08, 2018 Filed Aug 9, 2018 21:27 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $54.08 | $0.00 |
DisclosureSEC source: 0001021561-18-000123 · edgar.xml · derivative · entry 8 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 4,000 shares Expires 2019-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| August 08, 2018 Filed Aug 9, 2018 21:27 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 10,000 | $82.02 | $820,200.00 |
DisclosureSEC source: 0001021561-18-000123 · edgar.xml · nonDerivative · entry 3 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,416 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.00 to $82.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| August 08, 2018 Filed Aug 9, 2018 21:27 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 6,000 | $41.49 | $248,940.00 |
DisclosureSEC source: 0001021561-18-000123 · edgar.xml · nonDerivative · entry 2 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2018 Filed Aug 9, 2018 21:27 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 4,000 | $54.08 | $216,320.00 |
DisclosureSEC source: 0001021561-18-000123 · edgar.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2018 Filed Aug 7, 2018 22:01 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,250 | $0.00 Strike: $54.08 | $0.00 |
DisclosureSEC source: 0001021561-18-000119 · edgar.xml · derivative · entry 6 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Class A Common Stock · 2,250 shares Expires 2019-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| August 07, 2018 Filed Aug 7, 2018 22:01 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,250 | $0.00 Strike: $39.35 | $0.00 |
DisclosureSEC source: 0001021561-18-000119 · edgar.xml · derivative · entry 5 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 6,250 shares Expires 2018-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| August 07, 2018 Filed Aug 7, 2018 22:01 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 8,500 | $84.21 | $715,785.00 |
DisclosureSEC source: 0001021561-18-000119 · edgar.xml · nonDerivative · entry 3 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,416 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.00 to $84.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| August 07, 2018 Filed Aug 7, 2018 22:01 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 2,250 | $54.08 | $121,680.00 |
DisclosureSEC source: 0001021561-18-000119 · edgar.xml · nonDerivative · entry 2 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,916 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2018 Filed Aug 7, 2018 22:01 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 6,250 | $39.35 | $245,937.50 |
DisclosureSEC source: 0001021561-18-000119 · edgar.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 21:11 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantClass A Common Stock | 1,479 | $0.00 | $0.00 |
DisclosureSEC source: 0001021561-18-000046 · edgar.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,923 Read SEC document |
| March 08, 2018 Filed May 4, 2018 20:56 UTC Amendment | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantClass A Common Stock | 1,972 | $0.00 | $0.00 |
DisclosureSEC source: 0001021561-18-000069 · edgar.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,416 F1 · balance_after: Represents the Reporting Person's holdings as of March 8, 2018. Read SEC document |
| March 04, 2018 Filed Mar 6, 2018 22:51 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 499 | $72.35 | $36,102.65 |
DisclosureSEC source: 0001021561-18-000036 · edgar.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,444 F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 22:51 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantEmployee Stock Option (right to buy) · Derivative | 8,339 | $0.00 Strike: $50.68 | $0.00 |
DisclosureSEC source: 0001021561-18-000036 · edgar.xml · derivative · entry 4 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,339 Underlying: Class A Common Stock · 8,339 shares Expires 2024-03-04 F4 · shares: On March 4, 2017, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On March 2, 2018, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 22:51 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantEmployee Stock Option (right to buy) · Derivative | 16,138 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001021561-18-000036 · edgar.xml · derivative · entry 3 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,934 Underlying: Class A Common Stock · 16,138 shares Expires 2023-03-02 F3 · shares: On March 2, 2016, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On March 2, 2018, the performance criteria were met, resulting in the vesting of the amount shown above. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 23:45 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 13,750 | $0.00 Strike: $31.92 | $0.00 |
DisclosureSEC source: 0001021561-18-000030 · edgar.xml · derivative · entry 4 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 13,750 shares Expires 2018-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: In accordance with the terms of the Issuer's stock incentive plans, these options were automatically net exercised immediately prior to their expiration. F5 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 23:45 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 8,873 | $70.40 | $624,659.20 |
DisclosureSEC source: 0001021561-18-000030 · edgar.xml · nonDerivative · entry 2 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,943 F2 · shares: In accordance with the terms of the Issuer's stock incentive plans, these shares were withheld by the Issuer to cover the option exercise price and tax withholding obligations related to the automatic net exercise of options immediately prior to their expiration. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 23:45 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 13,750 | $31.92 | $438,900.00 |
DisclosureSEC source: 0001021561-18-000030 · edgar.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: In accordance with the terms of the Issuer's stock incentive plans, these shares were acquired from the automatic net exercise of options immediately prior to their expiration. Read SEC document |
| November 10, 2017 Filed Nov 13, 2017 21:25 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 36,503 | $0.00 Strike: $30.43 | $0.00 |
DisclosureSEC source: 0001021561-17-000132 · edgar.xml · derivative · entry 7 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 36,503 shares Expires 2017-11-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| November 10, 2017 Filed Nov 13, 2017 21:25 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 36,503 | $62.24 | $2,271,946.72 |
DisclosureSEC source: 0001021561-17-000132 · edgar.xml · nonDerivative · entry 4 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,066 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| November 10, 2017 Filed Nov 13, 2017 21:25 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 36,503 | $30.43 | $1,110,786.29 |
DisclosureSEC source: 0001021561-17-000132 · edgar.xml · nonDerivative · entry 3 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 21:25 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 13,497 | $0.00 Strike: $30.43 | $0.00 |
DisclosureSEC source: 0001021561-17-000132 · edgar.xml · derivative · entry 6 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,503 Underlying: Class A Common Stock · 13,497 shares Expires 2017-11-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 21:25 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 13,497 | $62.06 | $837,623.82 |
DisclosureSEC source: 0001021561-17-000132 · edgar.xml · nonDerivative · entry 2 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,066 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 21:25 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 13,497 | $30.43 | $410,713.71 |
DisclosureSEC source: 0001021561-17-000132 · edgar.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 20:15 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,688 | $0.00 Strike: $25.57 | $0.00 |
DisclosureSEC source: 0001021561-17-000112 · edgar.xml · derivative · entry 4 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 4,688 shares Expires 2017-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: In accordance with the terms of the Issuer's stock incentive plans, these options were automatically net exercised immediately prior to their expiration. F5 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 20:15 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 2,850 | $60.83 | $173,365.50 |
DisclosureSEC source: 0001021561-17-000112 · edgar.xml · nonDerivative · entry 2 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,066 F2 · shares: In accordance with the terms of the Issuer's stock incentive plans, these shares were withheld by the Issuer to cover the option exercise price and tax withholding obligations related to the automatic net exercise of options immediately prior to their expiration. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 20:15 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 4,688 | $25.57 | $119,872.16 |
DisclosureSEC source: 0001021561-17-000112 · edgar.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,916 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: In accordance with the terms of the Issuer's stock incentive plans, these shares were acquired from the automatic net exercise of options immediately prior to their expiration. Read SEC document |
| June 28, 2017 Filed Jun 29, 2017 22:40 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,125 | $0.00 Strike: $25.89 | $0.00 |
DisclosureSEC source: 0001021561-17-000098 · edgar.xml · derivative · entry 4 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 3,125 shares Expires 2017-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: In accordance with the terms of the Issuer's stock incentive plans, these options were automatically net exercised immediately prior to their expiration. F5 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| June 28, 2017 Filed Jun 29, 2017 22:40 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 1,881 | $62.91 | $118,333.71 |
DisclosureSEC source: 0001021561-17-000098 · edgar.xml · nonDerivative · entry 2 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,228 F2 · shares: In accordance with the terms of the Issuer's stock incentive plans, these shares were withheld by the Issuer to cover the option exercise price and tax withholding obligations related to the automatic net exercise of options immediately prior to their expiration. Read SEC document |
| June 28, 2017 Filed Jun 29, 2017 22:40 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 3,125 | $25.89 | $80,906.25 |
DisclosureSEC source: 0001021561-17-000098 · edgar.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,109 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: In accordance with the terms of the Issuer's stock incentive plans, these shares were acquired from the automatic net exercise of options immediately prior to their expiration. Read SEC document |
| March 04, 2017 Filed Mar 7, 2017 02:11 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantClass A Common Stock | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001021561-17-000032 · edgar.xml · nonDerivative · entry 3 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,766 Read SEC document |
| March 02, 2017 Filed Mar 7, 2017 02:11 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,625 | $0.00 Strike: $28.09 | $0.00 |
DisclosureSEC source: 0001021561-17-000032 · edgar.xml · derivative · entry 5 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 5,625 shares Expires 2017-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: In accordance with the terms of the Issuer's stock incentive plans, these options were automatically net exercised immediately prior to their expiration. F5 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| March 02, 2017 Filed Mar 7, 2017 02:11 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 3,972 | $50.00 | $198,600.00 |
DisclosureSEC source: 0001021561-17-000032 · edgar.xml · nonDerivative · entry 2 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,266 F2 · shares: In accordance with the terms of the Issuer's stock incentive plans, these shares were withheld by the Issuer to cover the option exercise price and tax withholding obligations related to the automatic net exercise of options immediately prior to their expiration. Read SEC document |
| March 02, 2017 Filed Mar 7, 2017 02:11 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 5,625 | $28.09 | $158,006.25 |
DisclosureSEC source: 0001021561-17-000032 · edgar.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,238 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: In accordance with the terms of the Issuer's stock incentive plans, these shares were acquired from the automatic net exercise of options immediately prior to their expiration. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.